These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1837979)

  • 21. Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation.
    Assini FL; Duzzioni M; Takahashi RN
    Behav Brain Res; 2009 Dec; 204(1):206-11. PubMed ID: 19523494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site.
    Lench AM; Robson E; Jones RS
    PLoS One; 2015; 10(7):e0133548. PubMed ID: 26193112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by D-cycloserine.
    Billard JM; Rouaud E
    Eur J Neurosci; 2007 Apr; 25(8):2260-8. PubMed ID: 17445224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing and impairing extinction of habit memory through modulation of NMDA receptors in the dorsolateral striatum.
    Goodman J; Ressler RL; Packard MG
    Neuroscience; 2017 Jun; 352():216-225. PubMed ID: 28377177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices.
    Rouaud E; Billard JM
    Br J Pharmacol; 2003 Nov; 140(6):1051-6. PubMed ID: 14530208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.
    Goff DC
    Schizophr Bull; 2012 Sep; 38(5):936-41. PubMed ID: 22368237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
    Tsai GE; Falk WE; Gunther J; Coyle JT
    Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
    Pitkänen M; Sirviö J; MacDonald E; Niemi S; Ekonsalo T; Riekkinen P
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):457-63. PubMed ID: 8998397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of cholinergic and glutamatergic neuronal systems in the functional activation of cerebral blood flow response: a PET study in unanesthetized monkeys.
    Tsukada H; Kakiuchi T; Shizuno H; Nishiyama S
    Brain Res; 1998 Jun; 796(1-2):82-90. PubMed ID: 9689457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling dementia: effects of scopolamine on memory and attention.
    Broks P; Preston GC; Traub M; Poppleton P; Ward C; Stahl SM
    Neuropsychologia; 1988; 26(5):685-700. PubMed ID: 3211287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-cycloserine rescues scopolamine-induced deficits in cognitive flexibility in rats measured by the attentional set-shifting task.
    Siddik MAB; Fendt M
    Behav Brain Res; 2022 Aug; 431():113961. PubMed ID: 35691513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice.
    Almasi-Nasrabadi M; Javadi-Paydar M; Mahdavian S; Babaei R; Sharifian M; Norouzi A; Dehpour AR
    Behav Brain Res; 2012 May; 231(1):138-45. PubMed ID: 22440233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions.
    Langton JM; Richardson R
    Neuropsychopharmacology; 2008 Dec; 33(13):3096-102. PubMed ID: 18354389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The memory-ameliorating effects of Artemisia princeps var. orientalis against cholinergic dysfunction in mice.
    Liu X; Kim DH; Kim JM; Park SJ; Cai M; Jang DS; Ryu JH
    Am J Chin Med; 2012; 40(5):993-1005. PubMed ID: 22928830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of riluzole to the basolateral amygdala facilitates fear extinction in rats.
    Sugiyama A; Yamada M; Saitoh A; Oka JI; Yamada M
    Behav Brain Res; 2018 Jan; 336():8-14. PubMed ID: 28843863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.
    Baran H; Löscher W; Mevissen M
    Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review.
    Schade S; Paulus W
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26364274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.